# An Effective and Compliance Regimen of Paclitaxel Plus Cisplatin to Treat Metastatic Breast Cancer

> **NCT00270569** · PHASE2 · UNKNOWN · sponsor: **Far Eastern Memorial Hospital** · enrollment: 43 (estimated)

## Conditions studied

- Breast Neoplasms

## Interventions

- **DRUG:** PhyxolTM, Cisplatin

## Key facts

- **NCT ID:** NCT00270569
- **Lead sponsor:** Far Eastern Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-10
- **Primary completion:** 2007-02
- **Final completion:** —
- **Target enrollment:** 43 (ESTIMATED)
- **Last updated:** 2009-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00270569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00270569, "An Effective and Compliance Regimen of Paclitaxel Plus Cisplatin to Treat Metastatic Breast Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00270569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*